Aclidinium improves exercise endurance, dyspnea, lung hyperinflation, and physical activity in patients with COPD: a randomized, placebo-controlled, crossover trial

被引：0

作者：

Kai M Beeh

Henrik Watz

Luis Puente-Maestu

Luis de Teresa

Diana Jarreta

Cynthia Caracta

Esther Garcia Gil

Helgo Magnussen

机构：

[1] insaf Respiratory Research Institute,Pulmonary Research Institute at LungClinic Grosshansdorf, Airway Research Centre North

[2] German Centre for Lung Research,Formerly of Forest Research Institute, Forest Laboratories LLC

[3] Hospital General Universitario Gregorio Marañón-Universidad Complutense,undefined

[4] Hospital de San Vicente,undefined

[5] AstraZeneca PLC,undefined

[6] a subsidiary of Actavis,undefined

来源：

BMC Pulmonary Medicine | / 14卷

关键词：

Aclidinium; COPD; Exercise endurance; Long-acting muscarinic antagonists; Physical activity;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

共 50 条

[31] Efficacy and safety of fixed-dose combinations of aclidinium bromide/formoterol fumarate: the 24-week, randomized, placebo-controlled AUGMENT COPD study
D'Urzo, Anthony D.
Rennard, Stephen I.
Kerwin, Edward M.
Mergel, Victor
Leselbaum, Anne R.
Caracta, Cynthia F.
RESPIRATORY RESEARCH, 2014, 15
[32] Effects of ghrelin on the dyspnea pattern in cachectic COPD: Exploratory analysis of a substudy of a multicenter, randomized, double-blind, placebo-controlled trial of ghrelin treatment
Miki, Keisuke
Maekura, Ryoji
Nagaya, Noritoshi
Kitada, Seigo
Miki, Mari
Yoshimura, Kenji
Matsui, Hideki
Satomi, Akitoshi
Hashimoto, HIsako
Mori, Masahide
Kangawa, Kenji
EUROPEAN RESPIRATORY JOURNAL, 2013, 42
[33] Effect of MS14® on physical activity of multiple sclerosis patients: A randomized triple-blind placebo-controlled clinical trial
Rezaeizadeh, Hossein
Gharegozli, Kourosh
Nabavi, Seyed Masood
Shayegannejad, Vahid
Ghaffarpoor, Majid
Daneshfard, Babak
Cordato, Dennis
Naseri, Mohsen
MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2023, 69
[34] Tiotropium in patients with moderate COPD naive to maintenance therapy: a randomised placebo-controlled trial
Troosters, Thierry y
Sciurba, Frank C.
Decramer, Marc
Siafakas, Nikos M.
Klioze, Solomon S.
Sutradhar, Santosh C.
Weisman, Idelle M.
Yunis, Carla
NPJ PRIMARY CARE RESPIRATORY MEDICINE, 2014, 24
[35] Addition of vitamin B12 to exercise training improves cycle ergometer endurance in advanced COPD patients: A randomized and controlled study
Paulin, Fernanda Viana
Zagatto, Alessandro Moura
Chiappa, Gaspar R.
Mueller, Paulo De Tarso
RESPIRATORY MEDICINE, 2017, 122 : 23 - 29
[36] Randomized double-blind placebo-controlled crossover study of caffeine in patients with intermittent claudication
Momsen, A. H.
Jensen, M. B.
Norager, C. B.
Madsen, M. R.
Vestersgaard-Andersen, T.
Lindholt, J. S.
BRITISH JOURNAL OF SURGERY, 2010, 97 (10) : 1503 - 1510
[37] Short-term Effects of Supplemental Oxygen on 6-Min Walk Test Outcomes in Patients With COPD A Randomized, Placebo-Controlled, Single-blind, Crossover Trial
Jarosch, Inga
Gloeckl, Rainer
Damm, Eva
Schwedhelm, Anna-Lena
Buhrow, David
Jerrentrup, Andreas
Spruit, Martijn A.
Kenn, Klaus
CHEST, 2017, 151 (04) : 795 - 803
[38] The effect of vitamin D on COPD exacerbation: A double blind randomized placebo-controlled parallel clinical trial
Sanjari M.
Soltani A.
Habibi Khorasani A.
Zareinejad M.
Journal of Diabetes & Metabolic Disorders, 15 (1)
[39] Assessment of Pain and Activity Using an Electronic Pain Diary and Actigraphy Device in a Randomized, Placebo-Controlled Crossover Trial of Celecoxib in Osteoarthritis of the Knee
Trudeau, Jeremiah
Van Inwegen, Richard
Eaton, Thomas
Bhat, Gajanan
Paillard, Florence
Ng, Dik
Tan, Keith
Katz, Nathaniel P.
PAIN PRACTICE, 2015, 15 (03) : 247 - 255
[40] In-hospital physiotherapy improves physical activity level after lung cancer surgery: a randomized controlled trial
Jonsson, Marcus
Hurtig-Wennlof, Anita
Ahlsson, Anders
Vidlund, Marten
Cao, Yang
Westerdahl, Elisabeth
PHYSIOTHERAPY, 2019, 105 (04) : 434 - 441

← 1 2 3 4 5 →